Viral Respiratory Infections in the Morbidity and Mortality of Airway Diseases and Immunocompromised...
-
Upload
juniper-allen -
Category
Documents
-
view
223 -
download
1
Transcript of Viral Respiratory Infections in the Morbidity and Mortality of Airway Diseases and Immunocompromised...
![Page 1: Viral Respiratory Infections in the Morbidity and Mortality of Airway Diseases and Immunocompromised States Acute and Chronic Bronchitis, COPD, Asthma,](https://reader036.fdocuments.in/reader036/viewer/2022062300/56649d095503460f949db0cc/html5/thumbnails/1.jpg)
Viral Respiratory Viral Respiratory Infections in theInfections in theMorbidity and MortalityMorbidity and Mortalityof Airway Diseases andof Airway Diseases and Immunocompromised Immunocompromised StatesStatesAcute and Chronic Bronchitis,Acute and Chronic Bronchitis,COPD, Asthma, Cystic Fibrosis,COPD, Asthma, Cystic Fibrosis,and Immunocompromisedand ImmunocompromisedCancer PatientsCancer Patients
![Page 2: Viral Respiratory Infections in the Morbidity and Mortality of Airway Diseases and Immunocompromised States Acute and Chronic Bronchitis, COPD, Asthma,](https://reader036.fdocuments.in/reader036/viewer/2022062300/56649d095503460f949db0cc/html5/thumbnails/2.jpg)
Frequency, Seasonality, Frequency, Seasonality, and Characteristics of and Characteristics of Viral Respiratory Viral Respiratory Infections (VRIs)Infections (VRIs)
![Page 3: Viral Respiratory Infections in the Morbidity and Mortality of Airway Diseases and Immunocompromised States Acute and Chronic Bronchitis, COPD, Asthma,](https://reader036.fdocuments.in/reader036/viewer/2022062300/56649d095503460f949db0cc/html5/thumbnails/3.jpg)
• Recognized for the last century as the most common infectious illness in humans
• Terminology has varied– Common respiratory infection– Common cold– Rhinosinusitis
• Rhinoviruses (RVs) cause a majority of these infections
Impact of VRIsImpact of VRIs
Monto AS et al. Clin Ther. 2001;1615.
![Page 4: Viral Respiratory Infections in the Morbidity and Mortality of Airway Diseases and Immunocompromised States Acute and Chronic Bronchitis, COPD, Asthma,](https://reader036.fdocuments.in/reader036/viewer/2022062300/56649d095503460f949db0cc/html5/thumbnails/4.jpg)
• Adults average ~2 to 4 colds1,2 and children average 3 to 8 colds3 per year
• In 1996, colds were associated with ~148 million days restricted activity, 20 million days missed work, 22 million days missed school, 45 million days bedridden4
• In 1998, 25 million office visits to primary care providers for upper respiratory infections (URIs)5
• Costs associated with VRIs estimated at ~$25 billion annually6
1. Turner RB. Pediatr Ann. 1998;27:790. 2. Monto AS et al. Clin Ther. 2001;23:1615.3. Rosenstein N et al. Pediatrics. 1998;101:181 4. Adams PF et al. Vital Health Stat. 1999;10 (200). 5. Gonzales R et al. Clin Infect Dis. 2001;33:757.6. Fendrick AM et al. Value in Health. 2001;4:412.
Economic and Societal BurdenEconomic and Societal Burdenof VRIsof VRIs
![Page 5: Viral Respiratory Infections in the Morbidity and Mortality of Airway Diseases and Immunocompromised States Acute and Chronic Bronchitis, COPD, Asthma,](https://reader036.fdocuments.in/reader036/viewer/2022062300/56649d095503460f949db0cc/html5/thumbnails/5.jpg)
Mea
n a
nn
ual
illn
ess
inci
den
ce
Reprinted from Monto AS, Ullman BM. JAMA. 1974;227:164.
Age group (yr)
7
6
5
4
3
2
1
0 1 1–2 3–4 5–9 10–14 15–19 20–24 25–29 30–39 40–49 50–59 60
Mean Annual Incidence of Respiratory Mean Annual Incidence of Respiratory Illnesses per Person-Year, Tecumseh, Illnesses per Person-Year, Tecumseh, Michigan, 1965–1971Michigan, 1965–1971
Females
Males
![Page 6: Viral Respiratory Infections in the Morbidity and Mortality of Airway Diseases and Immunocompromised States Acute and Chronic Bronchitis, COPD, Asthma,](https://reader036.fdocuments.in/reader036/viewer/2022062300/56649d095503460f949db0cc/html5/thumbnails/6.jpg)
30
25
20
15
10
5
0
Per
cen
t
RV Parainfluenza viruses
Per
cen
t
Respiratory syncytial virus (RSV) Influenza virus30
25
20
15
10
5
0Jan Apr Sep Oct Nov Dec Jan Feb Mar Apr May Jun Jan Apr Sep Oct Nov Dec Jan Feb Mar Apr May Jun
Reprinted from Br J Prev Soc Med, 1977;31:101-108, with permission from the BMJ Publishing Group.
Seasonality of Respiratory Agents: Proportion Seasonality of Respiratory Agents: Proportion Isolated in Each Calendar Month During Isolated in Each Calendar Month During 6 Years of Tecumseh, Michigan, Study6 Years of Tecumseh, Michigan, Study
![Page 7: Viral Respiratory Infections in the Morbidity and Mortality of Airway Diseases and Immunocompromised States Acute and Chronic Bronchitis, COPD, Asthma,](https://reader036.fdocuments.in/reader036/viewer/2022062300/56649d095503460f949db0cc/html5/thumbnails/7.jpg)
• Transmission of viruses differs• Influenza
– Airborne transmission1
– Widespread outbreaks
• RVs– Closer contact required– Aerosol and direct2,3
– Households and schools are sites of transmission4
Transmission of Respiratory Transmission of Respiratory VirusesViruses
1. Goldman DA. Pediatr Infect Dis J. 2000;19(10 suppl):S97. 2. Gwaltney JM Jr, Hendley JO. Am J Epidemiol. 1982;116:828. 3. Dick EC et al. J Infect Dis. 1987;156:442. 4. Gwaltney JM Jr. In: Mandell GL, Bennett JE, Dolin R, eds. Principles and Practice of Infectious Diseases.
5th ed. Philadelphia: Churchill Livingstone; 2000:1940.
![Page 8: Viral Respiratory Infections in the Morbidity and Mortality of Airway Diseases and Immunocompromised States Acute and Chronic Bronchitis, COPD, Asthma,](https://reader036.fdocuments.in/reader036/viewer/2022062300/56649d095503460f949db0cc/html5/thumbnails/8.jpg)
Sore throatCoughActivity restrictionLower respiratory symptomsHeadache
Coryza
Per
cen
t
RV RSV Parainfluenza virus
Hemolyticstreptococci
Influenza A Influenza B
0
20
40
60
80
100
Characteristics of VRIs ofCharacteristics of VRIs ofKnown EtiologyKnown Etiology
Reprinted from Br J Prev Soc Med, 1977;31:101-108, with permission from the BMJ Publishing Group.
![Page 9: Viral Respiratory Infections in the Morbidity and Mortality of Airway Diseases and Immunocompromised States Acute and Chronic Bronchitis, COPD, Asthma,](https://reader036.fdocuments.in/reader036/viewer/2022062300/56649d095503460f949db0cc/html5/thumbnails/9.jpg)
Reprinted with permission from Monto AS et al. J Infect Dis. 1987;156:43. ©1987 by The University of Chicago. All rights reserved.
Characteristics of RV-Associated Characteristics of RV-Associated IllnessesIllnesses
Illness with indicated syndrome (%) Percent with
Age group (years)
No. of isolates
Lower respiratory
Upper respiratory
Laryngo- pharyngeal Other
Medianduration(days)
Activity restriction
Physician consultation
0–4 61 14.8 83.6 1.6 — 12 0 16.4
5–19 39 5.1 74.4 15.4 5.1 7 56.4 15.4
20–39 59 33.9 59.3 6.8 — 13 11.9 15.3
40 17 64.7 29.4 5.9 — 20 35.3 35.3
Total 176 23.8 68.2 6.8 1.2 12 19.9 17.6
![Page 10: Viral Respiratory Infections in the Morbidity and Mortality of Airway Diseases and Immunocompromised States Acute and Chronic Bronchitis, COPD, Asthma,](https://reader036.fdocuments.in/reader036/viewer/2022062300/56649d095503460f949db0cc/html5/thumbnails/10.jpg)
Adapted with permission from Arruda E et al. J Clin Microbiol. 1997;35:2864.
Clinical featureRV %
positive
First symptom (% of subjects) Sore throat Stuffy nose Runny nose Sneezing
391717
8
Most bothersome symptom (% of subjects) Runny nose Stuffy nose Sore throat Malaise
36201910
Median duration of symptoms (days) Cold episode Sleep disturbance Interference with daily activities
1147
Clinical Features and Duration of Clinical Features and Duration of Illness in Adults with RV ColdsIllness in Adults with RV Colds(n=276, RV confirmed by PCR or culture)(n=276, RV confirmed by PCR or culture)
![Page 11: Viral Respiratory Infections in the Morbidity and Mortality of Airway Diseases and Immunocompromised States Acute and Chronic Bronchitis, COPD, Asthma,](https://reader036.fdocuments.in/reader036/viewer/2022062300/56649d095503460f949db0cc/html5/thumbnails/11.jpg)
Reproduced with permission from Pediatrics, Vol. 102, Pages 291-295, Table 2. Copyright 1998.
Virus
RV
RSV
HCV
Total positive
Middle ear fluid, *No. (%)
22 (24%)
17 (18%)
7 (8%)
44 (48%)
Nasopharyngeal aspirate, †No. (%)
28 (30%)
21 (23%)
14 (15%)
57 (62%)
Infectedchildren, No. (%)
32 (35%)
26 (28%)
16 (17%)
69 (75%)
Detection of Viruses by RT-PCR in MiddleDetection of Viruses by RT-PCR in MiddleEar Fluid and Nasopharyngeal AspiratesEar Fluid and Nasopharyngeal Aspiratesfrom 92 Children with Acute Otitis Mediafrom 92 Children with Acute Otitis Media
*2 samples had both HRV and RSV RNA; †2 aspirates had both HRV and RSV RNA, and 1 had both RSV and HCV RNA. RV=rhinovirus; RSV=respiratory syncytial virus; HCV=human coronavirus.
![Page 12: Viral Respiratory Infections in the Morbidity and Mortality of Airway Diseases and Immunocompromised States Acute and Chronic Bronchitis, COPD, Asthma,](https://reader036.fdocuments.in/reader036/viewer/2022062300/56649d095503460f949db0cc/html5/thumbnails/12.jpg)
• Sinusitis is an extremely common part of the common cold syndrome
• RV has been detected in 50% of adult patients with sinusitis by RT-PCR of maxillary sinus brushings or nasal swabs1
• Frequency of association of RV infection with sinusitis suggests the common cold could be considered a rhinosinusitis2
RV in Acute SinusitisRV in Acute Sinusitis
1. Pitkäranta A et al. J Clin Microbial. 1997;35:1791.2. Gwaltney JM Jr. Clin Infect Dis. 1996;23:1209.
![Page 13: Viral Respiratory Infections in the Morbidity and Mortality of Airway Diseases and Immunocompromised States Acute and Chronic Bronchitis, COPD, Asthma,](https://reader036.fdocuments.in/reader036/viewer/2022062300/56649d095503460f949db0cc/html5/thumbnails/13.jpg)
• Respiratory viruses are common pathogens in acute bronchitis1
• Respiratory virus infection associated with cough1
– Influenza virus: 75%–93% of cases– Adenovirus: 45%–90%– RVs: 32%–60%– Coronavirus: 10%–50%
• 40% of nonasthmatic patients with acutebronchitis had FEV1 80% of predicted2
• Bronchial reactivity remained increased up to 5 weeks after episode of acute bronchitis2,3
VRIs and Acute BronchitisVRIs and Acute Bronchitis
1. Gwaltney JM Jr. In: Mandell GL, Bennett JE, Dolin R, eds. Principles and Practice of Infectious Diseases. 5th ed. Philadelphia: Churchill Livingstone; 2000:703.
2. Williamson HA Jr. J Fam Pract. 1987;25:251. 3. Hallett JS, Jacobs RL. Ann Allergy. 1985;55:568.
![Page 14: Viral Respiratory Infections in the Morbidity and Mortality of Airway Diseases and Immunocompromised States Acute and Chronic Bronchitis, COPD, Asthma,](https://reader036.fdocuments.in/reader036/viewer/2022062300/56649d095503460f949db0cc/html5/thumbnails/14.jpg)
• In persons 60–90 years of age with RV infection, median duration of illness was16 days
• 19% were confined to bed; 26% had restriction of daily activities
• 63% had lower respiratory tract symptoms;43% consulted their physician
• Burden of RV infection in the elderly appears to exceed that of influenza
Nicholson KG et al. BMJ. 1996;313:1119.
RV Infection in the ElderlyRV Infection in the Elderly
![Page 15: Viral Respiratory Infections in the Morbidity and Mortality of Airway Diseases and Immunocompromised States Acute and Chronic Bronchitis, COPD, Asthma,](https://reader036.fdocuments.in/reader036/viewer/2022062300/56649d095503460f949db0cc/html5/thumbnails/15.jpg)
Reprinted from Wald TG et al. Ann Intern Med. 1995;123:588.
Upper respiratoryCoughCoryzaNasal or sinus congestionSore throat
TotalLower respiratory
Productive coughDyspneaHoarseness
TotalGastrointestinal
AnorexiaNausea, vomiting, or diarrhea
TotalSystemic
Malaise or fatigueMyalgiaSweating or chills
Total
34 (97)31 (89)21 (60)18 (51)
35 (100)
19 (54) 8 (23) 5 (14)23 (66)
11 (31) 4 (11)12 (34)
23 (66) 8 (23) 5 (14)25 (71)
Symptom No. of patients (%)
Symptoms of RV Infection in Symptoms of RV Infection in 35 Culture-Documented Illnesses 35 Culture-Documented Illnesses in a Long-Term Care Facilityin a Long-Term Care Facility
![Page 16: Viral Respiratory Infections in the Morbidity and Mortality of Airway Diseases and Immunocompromised States Acute and Chronic Bronchitis, COPD, Asthma,](https://reader036.fdocuments.in/reader036/viewer/2022062300/56649d095503460f949db0cc/html5/thumbnails/16.jpg)
• VRIs are the most common infectious diseases worldwide
• RVs are predominant cause of VRIs in allage groups
• Transmission requires relatively close contact
• Family and school major sites of transmission• RV infections peak in autumn, with minor spring
peaks• RVs cause AOM, sinusitis, and bronchitis in
otherwise healthy people
SummarySummary
![Page 17: Viral Respiratory Infections in the Morbidity and Mortality of Airway Diseases and Immunocompromised States Acute and Chronic Bronchitis, COPD, Asthma,](https://reader036.fdocuments.in/reader036/viewer/2022062300/56649d095503460f949db0cc/html5/thumbnails/17.jpg)
Role of VRIs in Asthma Role of VRIs in Asthma Exacerbations Exacerbations
![Page 18: Viral Respiratory Infections in the Morbidity and Mortality of Airway Diseases and Immunocompromised States Acute and Chronic Bronchitis, COPD, Asthma,](https://reader036.fdocuments.in/reader036/viewer/2022062300/56649d095503460f949db0cc/html5/thumbnails/18.jpg)
• Poor underlying control
• Environmental factors– VRIs
– Allergen exposure
– Air pollution
– Bacterial infections
– Stress
– Exercise/cold air
– Occupational exposure
Causes of Asthma ExacerbationsCauses of Asthma Exacerbations
![Page 19: Viral Respiratory Infections in the Morbidity and Mortality of Airway Diseases and Immunocompromised States Acute and Chronic Bronchitis, COPD, Asthma,](https://reader036.fdocuments.in/reader036/viewer/2022062300/56649d095503460f949db0cc/html5/thumbnails/19.jpg)
Reprinted from BMJ. 1995;310:1225-1229, with permission from the BMJ Publishing Group.
Virus
Picornaviruses 146 47 147
Coronavirus 17 14 21 38
Influenza viruses 14 10 20 21
Parainfluenza viruses 1, 2, and 3 6 6 18 21
RSV 6 6 12 12
Other 2 1 2 3
Method of detection
Viruses Detected During Asthma Viruses Detected During Asthma Exacerbations in ChildrenExacerbations in Children
*84 identified as RV on further testing.ELISA=enzyme-linked immunosorbent assay.
PCR CultureImmuno-
fluorescenceAntibody rise
by ELISA Total
*
![Page 20: Viral Respiratory Infections in the Morbidity and Mortality of Airway Diseases and Immunocompromised States Acute and Chronic Bronchitis, COPD, Asthma,](https://reader036.fdocuments.in/reader036/viewer/2022062300/56649d095503460f949db0cc/html5/thumbnails/20.jpg)
Hospital admissions for asthma correlate with virus isolation peaks and school terms.
Adapted with permission from Johnston SL et al. Am J Respir Crit Care Med. 1996;154:654. Official Journalof the American Thoracic Society. ©American Lung Association.
VRIs and Hospitalizations VRIs and Hospitalizations for Asthmafor Asthma
Total pediatric andadult hospitalizations
School holidays
URIs
0
5
10
15
20
Apr May Jun Jul Aug Sep Oct Nov Dec Jan Feb Mar
![Page 21: Viral Respiratory Infections in the Morbidity and Mortality of Airway Diseases and Immunocompromised States Acute and Chronic Bronchitis, COPD, Asthma,](https://reader036.fdocuments.in/reader036/viewer/2022062300/56649d095503460f949db0cc/html5/thumbnails/21.jpg)
• Comparison of wheezing and nonwheezing (control) children– Age, atopic status, eosinophil markers
• In wheezing children <2 years old– Respiratory viruses detected in 82% (18/22)– RSV predominant, 68% (15/22)
• In wheezing children 2 years old– Respiratory viruses detected in 83% (40/48)– RV predominant, 71% (34/48)– +PCR for RV and nasal eosinophilia or elevated nasal
ECP, 48% (23/48)
Rakes GP et al. Am J Respir Crit Care Med. 1999;159:785.
Children with Wheezing Children with Wheezing Presenting to the ERPresenting to the ER
![Page 22: Viral Respiratory Infections in the Morbidity and Mortality of Airway Diseases and Immunocompromised States Acute and Chronic Bronchitis, COPD, Asthma,](https://reader036.fdocuments.in/reader036/viewer/2022062300/56649d095503460f949db0cc/html5/thumbnails/22.jpg)
RV=rhinovirus; HCV=human coronavirus; RSV=respiratory syncytial virus.Nicholson KG et al. BMJ. 1993;307:982.
Pathogen
RVHCV OC43HCV 229EInfluenza BParainfluenzaRSVChlamydia psittaciDual infection
Number
76 21 15 2 5 2 3 5
Percent ofall episodes
33.2 9.2 6.6 0.9 2.2 0.9 1.3 2.2
Viruses Detected in 229 Viruses Detected in 229 Symptomatic Asthma Episodes Symptomatic Asthma Episodes in Adultsin Adults
![Page 23: Viral Respiratory Infections in the Morbidity and Mortality of Airway Diseases and Immunocompromised States Acute and Chronic Bronchitis, COPD, Asthma,](https://reader036.fdocuments.in/reader036/viewer/2022062300/56649d095503460f949db0cc/html5/thumbnails/23.jpg)
Data from Teichtahl H et al. Chest. 1997;112:591.
Viruses Detected in Adult Patients Viruses Detected in Adult Patients Hospitalized with AsthmaHospitalized with Asthma
54.5%
6.1%
27.3%
3% 3%Influenza AInfluenza BRVAdenovirusRSVHerpes
33 organisms isolated; 5 subjects had >1 virus detected and some viruses were detected by >1 test.
6.1%
![Page 24: Viral Respiratory Infections in the Morbidity and Mortality of Airway Diseases and Immunocompromised States Acute and Chronic Bronchitis, COPD, Asthma,](https://reader036.fdocuments.in/reader036/viewer/2022062300/56649d095503460f949db0cc/html5/thumbnails/24.jpg)
2 episodes of “common cold” beforeage 1 yr decrease risk of asthma by age 7by ~50%
• Other viral infections—eg, herpes, varicella, measles—also protective
• Reported LRI with wheeze in the first 3 years of life increases risk of asthma
Illi S et al. BMJ. 2001;322:390.
Respiratory Infections in Respiratory Infections in Infancy May Protect Against Infancy May Protect Against Development of AsthmaDevelopment of Asthma
![Page 25: Viral Respiratory Infections in the Morbidity and Mortality of Airway Diseases and Immunocompromised States Acute and Chronic Bronchitis, COPD, Asthma,](https://reader036.fdocuments.in/reader036/viewer/2022062300/56649d095503460f949db0cc/html5/thumbnails/25.jpg)
Children who had 2 older siblings or attended day care during first 6 mo of life had increased risk of wheeze early in life but decreased risk later.
Reprinted with permission from Ball TM et al. N Engl J Med. 2000;343:538. Copyright ©2000 Massachusetts Medical Society. All rights reserved.
P=0.01
P=0.03P=0.001
P<0.001P<0.001
2.7
1.0
0.4
1 2 3 4 5 6 7 8 9 10 11 12 13 14
Ad
just
ed r
elat
ive
risk
of
freq
uen
t w
hee
zin
g
Age (yr)
0.1
Effect of Day Care in Infancy and Effect of Day Care in Infancy and Number of Older Siblings onNumber of Older Siblings onAsthma RiskAsthma Risk
![Page 26: Viral Respiratory Infections in the Morbidity and Mortality of Airway Diseases and Immunocompromised States Acute and Chronic Bronchitis, COPD, Asthma,](https://reader036.fdocuments.in/reader036/viewer/2022062300/56649d095503460f949db0cc/html5/thumbnails/26.jpg)
• Viral infections (esp. RV) frequently cause exacerbations of asthma
• Possible mechanisms– Extension into the lower
airway1-3
– Inflammation2,3
Immunologic Mechanisms of VRI-Immunologic Mechanisms of VRI-Induced Asthma ExacerbationsInduced Asthma Exacerbations
1. Gern JE et al. Am J Respir Crit Care Med. 1997;155:1159.2. Gern JE, Busse WW. J Allergy Clin Immunol. 2000;106:201.3. Fraenkel DJ et al. Am J Respir Crit Care Med. 1995;151:879.
![Page 27: Viral Respiratory Infections in the Morbidity and Mortality of Airway Diseases and Immunocompromised States Acute and Chronic Bronchitis, COPD, Asthma,](https://reader036.fdocuments.in/reader036/viewer/2022062300/56649d095503460f949db0cc/html5/thumbnails/27.jpg)
AirwayHyperresponsiveness
Plasmaleakage
Mucus hypersecretion
Inflammatorycell recruitmentand activation
Neural activation
Virus-infected epithelium
Adapted from Gern JE, Busse WW. J Allergy Clin Immunol. 2000;106:201.
RV-Induced Airway InflammationRV-Induced Airway Inflammation
![Page 28: Viral Respiratory Infections in the Morbidity and Mortality of Airway Diseases and Immunocompromised States Acute and Chronic Bronchitis, COPD, Asthma,](https://reader036.fdocuments.in/reader036/viewer/2022062300/56649d095503460f949db0cc/html5/thumbnails/28.jpg)
• VRIs (especially RV infections in children >2 yr old) and atopy synergistically enhance the risk of wheezing1
– Antigen-specific IgE– Eosinophilic inflammation
• Cytokine production pattern is related to outcomes of experimental infection2
• High IFN-/IL-5 ratio=Th1-type (antiviral) response2
• Low IFN-/IL-5 ratio=Th2-type (allergic) response2
1. Rakes GP et al. Am J Respir Crit Care Med. 1999;159:785.2. Gern JE et al. Am J Respir Crit Care Med. 2000;162:2226.
What Is Different About VRIs in What Is Different About VRIs in Asthma?Asthma?
![Page 29: Viral Respiratory Infections in the Morbidity and Mortality of Airway Diseases and Immunocompromised States Acute and Chronic Bronchitis, COPD, Asthma,](https://reader036.fdocuments.in/reader036/viewer/2022062300/56649d095503460f949db0cc/html5/thumbnails/29.jpg)
• PBMC IFN- secretion– Reduced peak viral
shedding
• Sputum IFN-/IL-5 mRNA ratio correlates with– Lower symptom scores– More rapid viral
clearance
Parry DE et al. J Allergy Clin Immunol. 2000;105:692.Reprinted from Gern JE et al. Am J Respir Crit Care Med. 2000;162:2226.
Immunologic Risk Factors for Immunologic Risk Factors for More Severe VRIsMore Severe VRIs
Virus detected at 14 days?No Yes
IFN/
IL-5
rat
io (
un
its)
100
101
102
103
104
Th1Th1
Th2Th2
![Page 30: Viral Respiratory Infections in the Morbidity and Mortality of Airway Diseases and Immunocompromised States Acute and Chronic Bronchitis, COPD, Asthma,](https://reader036.fdocuments.in/reader036/viewer/2022062300/56649d095503460f949db0cc/html5/thumbnails/30.jpg)
• Viruses cause asthma exacerbations in adults and children
• RVs cause ~60% of virus-induced exacerbations of asthma
• RVs directly infect the bronchial airways
• The response to viral infection is shaped by the host’s antiviral response
• VRIs in early childhood may protect against the development of asthma
SummarySummary
![Page 31: Viral Respiratory Infections in the Morbidity and Mortality of Airway Diseases and Immunocompromised States Acute and Chronic Bronchitis, COPD, Asthma,](https://reader036.fdocuments.in/reader036/viewer/2022062300/56649d095503460f949db0cc/html5/thumbnails/31.jpg)
Role of VRI and RV in Role of VRI and RV in Acute Exacerbations of Acute Exacerbations of Chronic Bronchitis Chronic Bronchitis
![Page 32: Viral Respiratory Infections in the Morbidity and Mortality of Airway Diseases and Immunocompromised States Acute and Chronic Bronchitis, COPD, Asthma,](https://reader036.fdocuments.in/reader036/viewer/2022062300/56649d095503460f949db0cc/html5/thumbnails/32.jpg)
Cost of Acute Exacerbations of Cost of Acute Exacerbations of Chronic Bronchitis (AECB)Chronic Bronchitis (AECB)
• Hospitalization (500,000 episodes)– Total cost, $1.6 billion– Mean LOS, 6 days– Mean cost, $5500/patient
• Outpatient office visits 65 yr: 331,000, cost $24.9 million– <65 yr: 237,000, cost $15.1 million
• Indirect costs– Days lost from work– Lost productivity
.
Niederman MS et al. Clin Ther. 1999;21:576-591
![Page 33: Viral Respiratory Infections in the Morbidity and Mortality of Airway Diseases and Immunocompromised States Acute and Chronic Bronchitis, COPD, Asthma,](https://reader036.fdocuments.in/reader036/viewer/2022062300/56649d095503460f949db0cc/html5/thumbnails/33.jpg)
• Infectious, 80%– Bacterial pathogens, 40%–50%– Viruses, 30%–40%– Atypical bacteria, 5%–10%
• Noninfectious, 20% – Environmental factors– Noncompliance with medical therapy
Sethi S. Chest. 2000;117(suppl):380S.
AECB: EtiologyAECB: Etiology
![Page 34: Viral Respiratory Infections in the Morbidity and Mortality of Airway Diseases and Immunocompromised States Acute and Chronic Bronchitis, COPD, Asthma,](https://reader036.fdocuments.in/reader036/viewer/2022062300/56649d095503460f949db0cc/html5/thumbnails/34.jpg)
Data from Greenberg SB et al. Am J Respir Crit Care Med. 2000;162:167.
Viral AECB: PathogensViral AECB: Pathogens
0
5
10
15
20
25
30
35
Picorna-viruses
Para-influenzaviruses
Corona-viruses
Influenzaviruses
RSV Adeno-viruses
Control
FEV1 50%
FEV1 <50%
% o
f to
tal i
den
tifi
ed
![Page 35: Viral Respiratory Infections in the Morbidity and Mortality of Airway Diseases and Immunocompromised States Acute and Chronic Bronchitis, COPD, Asthma,](https://reader036.fdocuments.in/reader036/viewer/2022062300/56649d095503460f949db0cc/html5/thumbnails/35.jpg)
Virus-Associated Illness in Virus-Associated Illness in Controls and COPD PatientsControls and COPD Patients
2600% LRT symptoms alone
0.520.380.54No. VRIs/yr
31.81.4No. respiratory illnesses/yr
323055No. patients
FEV1 <50%FEV1 50%Controls
LRT = lower respiratory tract.Data from Greenberg SB et al. Am J Respir Crit Care Med. 2000;162:167.
![Page 36: Viral Respiratory Infections in the Morbidity and Mortality of Airway Diseases and Immunocompromised States Acute and Chronic Bronchitis, COPD, Asthma,](https://reader036.fdocuments.in/reader036/viewer/2022062300/56649d095503460f949db0cc/html5/thumbnails/36.jpg)
• FEV1<50% predicted – 52 hospitalizations
in 12 patients – 82% acute
exacerbations,22% pneumonia
– 5 of 6 deaths were COPD related
ER=emergency room.Data from Greenberg SB et al. Am J Respir Crit Care Med. 2000;162:167.
Viral AECB: Medical Resource Viral AECB: Medical Resource UtilizationUtilization
% V
RI
0
10
20
30
40
50
60
70
80
Office ER Hospital
Control
FEV1 50% predicted
FEV1 <50% predicted
100
![Page 37: Viral Respiratory Infections in the Morbidity and Mortality of Airway Diseases and Immunocompromised States Acute and Chronic Bronchitis, COPD, Asthma,](https://reader036.fdocuments.in/reader036/viewer/2022062300/56649d095503460f949db0cc/html5/thumbnails/37.jpg)
• AECB manifestations– Increased dyspnea, 76%– Increased sputum volume, 62% – Increased sputum purulence, 39%
• Anthonisen type– Type 1 (all 3 of above symptoms), 20%– Type 2 (2 of above symptoms), 46%– Type 3 (1 of above symptoms), 34%
• 64% of AECB associated with prior cold (18 days)
Seemungal T et al. Am J Respir Crit Care Med. 2001;164:1618.
Viral AECB: Clinical PresentationViral AECB: Clinical Presentation
![Page 38: Viral Respiratory Infections in the Morbidity and Mortality of Airway Diseases and Immunocompromised States Acute and Chronic Bronchitis, COPD, Asthma,](https://reader036.fdocuments.in/reader036/viewer/2022062300/56649d095503460f949db0cc/html5/thumbnails/38.jpg)
• 39.2% of AECB associated with viral infection
• Cold, increased dyspnea with cold, and sore throat associated with viral isolation
Data from Seemungal T et al. Am J Respir Crit Care Med. 2001;164:1618.
0
5
10
15
20
25
% o
f re
po
rted
exa
cerb
atio
ns
RV Corona Infl A Infl B Parainfl Adeno RSV
AECB: Viral Detection and AECB: Viral Detection and SymptomsSymptoms
![Page 39: Viral Respiratory Infections in the Morbidity and Mortality of Airway Diseases and Immunocompromised States Acute and Chronic Bronchitis, COPD, Asthma,](https://reader036.fdocuments.in/reader036/viewer/2022062300/56649d095503460f949db0cc/html5/thumbnails/39.jpg)
• AECB are associated with considerable morbidity, mortality, and health care costs
• VRIs are an important cause of AECB• RVs are frequently detected in the airway
secretions of patients with AECB
SummarySummary
![Page 40: Viral Respiratory Infections in the Morbidity and Mortality of Airway Diseases and Immunocompromised States Acute and Chronic Bronchitis, COPD, Asthma,](https://reader036.fdocuments.in/reader036/viewer/2022062300/56649d095503460f949db0cc/html5/thumbnails/40.jpg)
VRIs in Patients with VRIs in Patients with Cystic FibrosisCystic Fibrosis
![Page 41: Viral Respiratory Infections in the Morbidity and Mortality of Airway Diseases and Immunocompromised States Acute and Chronic Bronchitis, COPD, Asthma,](https://reader036.fdocuments.in/reader036/viewer/2022062300/56649d095503460f949db0cc/html5/thumbnails/41.jpg)
• Cause exacerbations and LRIs• Contribute to long-term pulmonary
deterioration, morbidity, mortality• Strongly associated with every measure of
CF disease progression1
• Contribute to initial bacterial colonization2
1. Wang EEL et al. N Engl J Med. 1984;311:1653.2. Armstrong et al. Pediatr Pulmonol. 1998;26:371.
Cystic Fibrosis (CF): Respiratory Cystic Fibrosis (CF): Respiratory VirusesViruses
![Page 42: Viral Respiratory Infections in the Morbidity and Mortality of Airway Diseases and Immunocompromised States Acute and Chronic Bronchitis, COPD, Asthma,](https://reader036.fdocuments.in/reader036/viewer/2022062300/56649d095503460f949db0cc/html5/thumbnails/42.jpg)
• Infection of epithelial cells– Release of proinflammatory mediators
– Attraction and activation of inflammatory cells
– Neutrophil release of prostaglandins and oxygen radicals
• Altered endothelial permeability
• Promotion of edema, enhanced cell recruitment
• Stimulation of mucus secretion
• Airway smooth muscle contraction
Prober CG. Clin Rev Allergy. 1991;9:87.
CF: Proposed Mechanisms ofCF: Proposed Mechanisms ofVirus-Induced ExacerbationVirus-Induced Exacerbation
![Page 43: Viral Respiratory Infections in the Morbidity and Mortality of Airway Diseases and Immunocompromised States Acute and Chronic Bronchitis, COPD, Asthma,](https://reader036.fdocuments.in/reader036/viewer/2022062300/56649d095503460f949db0cc/html5/thumbnails/43.jpg)
• VRIs are associated with clinical exacerbations of CF with disease progression
• Inflammatory response most likely mechanism by which VRIs exacerbate CF
• Viruses predispose to bacterial colonization and infection
SummarySummary
![Page 44: Viral Respiratory Infections in the Morbidity and Mortality of Airway Diseases and Immunocompromised States Acute and Chronic Bronchitis, COPD, Asthma,](https://reader036.fdocuments.in/reader036/viewer/2022062300/56649d095503460f949db0cc/html5/thumbnails/44.jpg)
VRIs in VRIs in Immunosuppressed Immunosuppressed Cancer PatientsCancer Patients
![Page 45: Viral Respiratory Infections in the Morbidity and Mortality of Airway Diseases and Immunocompromised States Acute and Chronic Bronchitis, COPD, Asthma,](https://reader036.fdocuments.in/reader036/viewer/2022062300/56649d095503460f949db0cc/html5/thumbnails/45.jpg)
Impairments in Viral ImmunityImpairments in Viral Immunityin BMT Recipients with Cancerin BMT Recipients with Cancer
• B lymphocytes– Reduced response to stimulatory cytokines (IL-4)– Reduced serum immunoglobulins– Depressed primary and secondary responses to antigens
• T lymphocytes– Reduced CD4 lymphocyte numbers– Reduced helper cell activity– Increased suppressor cell activity– Reduced proliferative responses– Reduced CD8 lymphocyte cytotoxic function
• Mucositis• Reduced IgA secretion
Couch RB et al. Am J Med. 1997;102(suppl 3A):2.
![Page 46: Viral Respiratory Infections in the Morbidity and Mortality of Airway Diseases and Immunocompromised States Acute and Chronic Bronchitis, COPD, Asthma,](https://reader036.fdocuments.in/reader036/viewer/2022062300/56649d095503460f949db0cc/html5/thumbnails/46.jpg)
• Allogeneic transplant
• Hematologic malignancy
• Graft-vs-host disease
• Corticosteroid therapy
• ? Conditioning regimen
• Lymphopenia (<200/mL)
• Age >65 years
• <100 days post-transplant
Risk Factors Associated withRisk Factors Associated withSerious Morbidity from VRIs inSerious Morbidity from VRIs inBMT RecipientsBMT Recipients
Sable CA, Donowitz GR. Clin Infect Dis. 1994;18:273.
![Page 47: Viral Respiratory Infections in the Morbidity and Mortality of Airway Diseases and Immunocompromised States Acute and Chronic Bronchitis, COPD, Asthma,](https://reader036.fdocuments.in/reader036/viewer/2022062300/56649d095503460f949db0cc/html5/thumbnails/47.jpg)
Important Features of VRIs in Important Features of VRIs in Immunocompromised PatientsImmunocompromised Patients
• High potential for nosocomial acquisition1 • Prolonged shedding of virus, even with
treatment2
• High frequency of pneumonia and death1
• Viral pneumonia often associated with other infections1
• Outbreaks can occur in absence of community epidemic1
1. Couch RB et al. Am J Med. 1997;102(suppl 3A):2.2. Bodey GP. Am J Med. 1997;102(suppl 3A):77.
![Page 48: Viral Respiratory Infections in the Morbidity and Mortality of Airway Diseases and Immunocompromised States Acute and Chronic Bronchitis, COPD, Asthma,](https://reader036.fdocuments.in/reader036/viewer/2022062300/56649d095503460f949db0cc/html5/thumbnails/48.jpg)
1. Data from Couch RB et al. Am J Med. 1997;102(suppl 3A):2.2. Data from Ghosh et al. Clin Infect Dis. 1999;29:528.
No. of infections leading to pneumonia
Pneumonia(% of infections)
Death (% of those
with pneumonia)*
LeukemiaBMT
BMT
2233
5961
3236
2720
7870
3325
945
6758
4422
22 32 100
Progression of VRIs inProgression of VRIs inLeukemia and BMTLeukemia and BMT
RSV1
Influenza
Parainfluenza
RV2
LeukemiaBMT
LeukemiaBMT
*Other pulmonary infections often present.
![Page 49: Viral Respiratory Infections in the Morbidity and Mortality of Airway Diseases and Immunocompromised States Acute and Chronic Bronchitis, COPD, Asthma,](https://reader036.fdocuments.in/reader036/viewer/2022062300/56649d095503460f949db0cc/html5/thumbnails/49.jpg)
• VRIs are an important cause of morbidity and mortality in immunosuppressed cancer patients
• Underlying disease and immunosuppressive therapy contribute to the high mortality rate in BMT patients with VRIs
SummarySummary
![Page 50: Viral Respiratory Infections in the Morbidity and Mortality of Airway Diseases and Immunocompromised States Acute and Chronic Bronchitis, COPD, Asthma,](https://reader036.fdocuments.in/reader036/viewer/2022062300/56649d095503460f949db0cc/html5/thumbnails/50.jpg)
Acute Respiratory Acute Respiratory Infections and Antibiotic Infections and Antibiotic Use: A Primary Care andUse: A Primary Care andHealth Services Health Services Research PerspectiveResearch Perspective
![Page 51: Viral Respiratory Infections in the Morbidity and Mortality of Airway Diseases and Immunocompromised States Acute and Chronic Bronchitis, COPD, Asthma,](https://reader036.fdocuments.in/reader036/viewer/2022062300/56649d095503460f949db0cc/html5/thumbnails/51.jpg)
Reprinted from Gonzales R et al. Clin Infect Dis. 2001;33:757.
Off
ice
visi
ts (
1000
)
0
5000
10,000
15,000
20,000
25,000
Office visits
Antibiotic prescription
Bacterial prevalence
Acute Respiratory Infections (ARIs):Acute Respiratory Infections (ARIs):PrimaryPrimary Care Office Visits, Antibiotic Use, Care Office Visits, Antibiotic Use, and Bacterial Prevalence in US, 1998and Bacterial Prevalence in US, 1998
30%
76%
70%
62%
59%
URI Otitis media Sinusitis Pharyngitis Bronchitis0
20
40
60
80
100
An
tibio
tic Rx an
d estim
atedb
acterial prevalen
ce (% o
f visits)
![Page 52: Viral Respiratory Infections in the Morbidity and Mortality of Airway Diseases and Immunocompromised States Acute and Chronic Bronchitis, COPD, Asthma,](https://reader036.fdocuments.in/reader036/viewer/2022062300/56649d095503460f949db0cc/html5/thumbnails/52.jpg)
Adapted from Gonzales R et al. Clin Infect Dis. 2001;33:757.
Estimated 55% of prescriptions (22.6 million) for ARIs are unnecessary, at a cost of $726 million.
No. of prescriptions Cost estimate
ARI diagnosis (millions) (millions)
Otitis media 9.6 $280
Pharyngitis 8.7 $215
URI 7.4 $227
Sinusitis 7.9 $310
Bronchitis 7.8 $289
Total 41.4 $1322
Estimated Annual Cost of Antibiotic Estimated Annual Cost of Antibiotic Use for ARIs in US, 1998Use for ARIs in US, 1998
![Page 53: Viral Respiratory Infections in the Morbidity and Mortality of Airway Diseases and Immunocompromised States Acute and Chronic Bronchitis, COPD, Asthma,](https://reader036.fdocuments.in/reader036/viewer/2022062300/56649d095503460f949db0cc/html5/thumbnails/53.jpg)
Adapted from Stone S et al. Ann Emerg Med. 2000;36:320.
Emergency Department Visits and Emergency Department Visits and Antibiotic Use for ARIs in US, 1996Antibiotic Use for ARIs in US, 1996
Condition Visits (millions) Antibiotic use
URIs, all 2.0 26%
URIs only* 1.6 24%
Bronchitis, all 2.1 42%
Bronchitis only* 1.2 42%
Otitis media 2.7 55%
Pharyngitis 1.5 52%
Total ARIs 8.1 44.5%
*Excludes patients with additional diagnoses of asthma, COPD, chronic bronchitis, pneumonia, otitis, pharyngitis, sinusitis, HIV.
![Page 54: Viral Respiratory Infections in the Morbidity and Mortality of Airway Diseases and Immunocompromised States Acute and Chronic Bronchitis, COPD, Asthma,](https://reader036.fdocuments.in/reader036/viewer/2022062300/56649d095503460f949db0cc/html5/thumbnails/54.jpg)
• Patients who expect antibiotics receive them more often1-3
• Strongest predictor of receipt of antibiotics for ARI isMD perception of patient expectation1,3
• Patient satisfaction more closely related to quality of communication (explanations, contingency plans) than receipt of antibiotics1,3,4
• Public beliefs about antibiotic effectiveness5
– Useful for VRI: 55%– Useful for bacterial but not viral illness: 21%
1. Hamm RM et al. J Fam Pract. 1996;43:56. 2. Bauchner H et al. Pediatrics. 1999;103:395. 3. Mangione-Smith R et al. Pediatrics. 1999;103:711. 4. Mangione-Smith R et al. Arch Pediatr Adolesc Med. 2001;155:800. 5. Wilson AA et al. J Gen Intern Med. 1999;14:658.
Use of Antibiotics: Patient Use of Antibiotics: Patient Expectations, Physician Perceptions, Expectations, Physician Perceptions, Public BeliefsPublic Beliefs
![Page 55: Viral Respiratory Infections in the Morbidity and Mortality of Airway Diseases and Immunocompromised States Acute and Chronic Bronchitis, COPD, Asthma,](https://reader036.fdocuments.in/reader036/viewer/2022062300/56649d095503460f949db0cc/html5/thumbnails/55.jpg)
• Pre-, post-intervention trial to decrease antibiotic use in acute, uncomplicated bronchitis in HMO sites
• Full intervention: household and office-based patient-education materials; clinician education, profiling, and academic detailing
• Limited intervention: office-based patient education materials
• Antibiotic use declined from 74% to 48% only at site with full intervention
• No differences in revisits, other prescriptions, other diagnosesGonzales R et al. JAMA. 1999;281:1512.
Decreasing Antibiotic OveruseDecreasing Antibiotic OveruseIs Hard But PossibleIs Hard But Possible
![Page 56: Viral Respiratory Infections in the Morbidity and Mortality of Airway Diseases and Immunocompromised States Acute and Chronic Bronchitis, COPD, Asthma,](https://reader036.fdocuments.in/reader036/viewer/2022062300/56649d095503460f949db0cc/html5/thumbnails/56.jpg)
• “Just Say No” to unnecessary antibiotics for ARI– Community and patient education– Office-based interventions– Clinician-oriented interventions
• Better technology for rapid diagnostic testing to identify bacterial vs viral illness
• Possible development of antiviral medications
SummarySummary
![Page 57: Viral Respiratory Infections in the Morbidity and Mortality of Airway Diseases and Immunocompromised States Acute and Chronic Bronchitis, COPD, Asthma,](https://reader036.fdocuments.in/reader036/viewer/2022062300/56649d095503460f949db0cc/html5/thumbnails/57.jpg)
• VRIs are an important cause of morbidity and increased health care costs
• RVs are the most common cause of VRIs
• RVs are also an important cause of morbidity in patients with asthma, COPD, and CF, and in immunocompromised patients
• In immunocompromised cancer patients, VRIs increase mortality and morbidity from pneumonia
• The mechanism of exacerbation of asthma, chronic bronchitis, and CF is related to the host inflammatory response
• Patients with VRIs are often prescribed antibiotics
Program SummaryProgram Summary
![Page 58: Viral Respiratory Infections in the Morbidity and Mortality of Airway Diseases and Immunocompromised States Acute and Chronic Bronchitis, COPD, Asthma,](https://reader036.fdocuments.in/reader036/viewer/2022062300/56649d095503460f949db0cc/html5/thumbnails/58.jpg)
ContributorsContributors
Gerald P. Bodey, Sr., MDThe University of Texas M. D. Anderson Cancer CenterHouston
Ethan A. Halm, MD, MPHMount Sinai School of MedicineNew York
James E. Gern, MDUniversity of WisconsinMadison
Sebastian L. Johnston, MDImperial College of Science, Technology and MedicineLondon, UK
Sanjay Sethi, MDState University of New YorkBuffalo
Homer A. Boushey, Jr., MD, EditorUniversity of CaliforniaSan Francisco
Arnold S. Monto, MDUniversity of Michigan School of Public HealthAnn Arbor
Harley A. Rotbart, MDUniversity of Colorado Health Sciences CenterDenver